DNA Topoisomerases and Radiation Responses

References

• Boothman D.A., Trask D.K., Pardee A.B. Inhibition of potentially lethal DNA damage repair in human tumor cells by beta-lapachone, an activator of topoisomerase I. Cancer Research 1989; 49: 605–612
   PubMed Web of Science ®Google Scholar
• Chung T.D.Y., Drake F.H., Tan K.B., Per S.R., Crooke S.T., Mirabelli C.K. Characterization and immunological identification of cDNA clones encoding two human DNA topoisomerase II isozymes. Proceedings of the National Academy of Sciences, USA 1989; 86: 9431–9435
   PubMed Web of Science ®Google Scholar
• Darroudi F., Natarajan A.T. Cytogenetical characterization of Chinese hamster ovary X-ray-sensitive mutant cells, xrs 5 and xrs 6. IV. Study of chromosomal aberrations and sister-chromatid exchanges by restriction endonucleases and inhibitors of DNA topoisomerase II. Mutation Research 1989; 212: 137–148
   PubMed Web of Science ®Google Scholar
• Davies S.M., Harris A.L., Hickson I.D. Overproduction of topoisomerase II in an ataxia telagiectasia fibroblast cell line: comparison with a topoisomerase II-overproducing hamster cell mutant. Nucleic Acids Research 1989; 17: 1337–1351
   PubMed Web of Science ®Google Scholar
• Downes C.S., Johnson R.T. DNA topoisomerases and DNA repair. BioEssays 1988; 8: 179–184
   PubMed Web of Science ®Google Scholar
• Dresler S., Robinson-Hill R.M. Direct inhibition of u.v.-induced DNA excision repair in human cells by novobiocin, coumermycin and nalidixic acid. Carcinogenesis 1987; 8: 813–817
   PubMed Web of Science ®Google Scholar
• Drlica K., Franco R.J. Inhibitors of DNA topoisomerases. Biochemistry 1988; 27: 2253–2259
   PubMed Web of Science ®Google Scholar
• Epstein R.J., Smith P.J. Estrogen-induced potentiation of DNA damage and cytotoxicity in human breast cancer cells treated with topoisomerase II-interactive antitumour drugs. Cancer Research 1988; 48: 297–303
   PubMed Web of Science ®Google Scholar
• Evans H.H., Ricanati M., Horng M.F., Mencl J. Relationship between topoisomerase II and radiosensitivity in mouse L5178Y lymphoma strains. Mutation Research 1989; 217: 53–63
   PubMed Web of Science ®Google Scholar
• Gedik C.M., Collins A.R. Comparison of the effects of fostriecin, novobiocin, and camptothecin, inhibitors of DNA topoisomerases, on DNA replication and repair in human cells. Nucleic Acids Research 1990; 18: 1007–1013
   PubMed Web of Science ®Google Scholar
• Heck M.M., Hittelman W.N., Earnshaw W.C. Differential expression of DNA topoisomerases I and II during the eukaryotic cell cycle. Proceedings of the National Academy of Sciences, USA 1988; 85: 1086–1090
   PubMed Web of Science ®Google Scholar
• Ivanov V.A. Variations in DNA topoisomerase I activity after gamma irradiation of mature neurons. Neuroscience Letters 1988; 94: 99–103
   PubMed Web of Science ®Google Scholar
• Jaxel C., Taudou G., Portemer C., Mirambeau G., Panijel J., Duguet M. Topoisomerase inhibitors induce irreversible fragmentation of replicated DNA in concanavalin A stimulated splenocytes. Biochemistry 1988; 27: 95–99
   PubMed Web of Science ®Google Scholar
• Johnstone A., McNerney R. Changes in topoisomerase I activity after irradiation of lymphoid cells. Bioscience Reports 1985; 5: 907–912
   PubMed Web of Science ®Google Scholar
• Kano Y., Fujiwara Y. Defective thymine dimer excision from xeroderma pigmentosum chromatin and its characteristic catalysis by cell-free extracts. Carcinogenesis 1983; 4: 1491–1424
   PubMed Web of Science ®Google Scholar
• Krupitza G., Cerutti P. ADP-ribosylation of ADPR-transferase and topoisomerase I in intact mouse epidermal cells JB6. Biochemistry 1989; 28: 2034–2040
   PubMed Web of Science ®Google Scholar
• Legerski R.J., Penkala J.E., Peterson C.A., Wright D.A. Repair of UV-induced lesions in Xenopus laevis oocytes. Molecular and Cellular Biology 1987; 7: 4317–4323
   PubMed Web of Science ®Google Scholar
• Liu L.F. DNA topoisomerase poisons as antitumour drugs. Annual Review of Biochemistry 1989; 58: 351–375
   PubMed Web of Science ®Google Scholar
• Mattern M.R., Mong S.M., Bartus H.F., Mirabelli C.K., Crooke S.T., Johnson R.K. Relationship between the intracellular effects of camptothecin and the inhibition of DNA topoisomerase I in cultured L1210 cells. Cancer Research 1987; 47: 1793–1798
   PubMed Web of Science ®Google Scholar
• McHugh M.M., Woynarowski J.M., Sigmund R.D., Beerman T.A. Effect of minor groove binding drugs on mammalian topoisomerase I activity. Biochemical Pharmacology 1989; 38: 2323–2328
   PubMed Web of Science ®Google Scholar
• Nitiss J., Wang J.C. DNA topoisomerase-targeting antitumor drugs can be studied in yeast. Proceedings of the National Academy of Sciences, USA 1988; 85: 7501–7505
   PubMed Web of Science ®Google Scholar
• Riou J-F., Lefevre D., Riou G. Stimulation of the topoisomerase II induced DNA cleavage sites in the c-myc protooncogene by antitumour drugs is associated with gene expression. Biochemistry 1989; 28: 9104–9110
   PubMed Web of Science ®Google Scholar
• Ripley L.S., Dubins J.S., DeBoer J.G., DeMarini D.M., Bogerd A.M., Kreuzer K.N. Hotspot sites for acridine-induced frameshift mutations in bacteriophage T4 correspond to sites of action of the T4 type II topoisomerase. Journal of Molecular Biology 1988; 200: 665–680
   PubMed Web of Science ®Google Scholar
• Schneider E., Lawson P.A., Ralph R.K. Inhibition of protein synthesis reduces the cytotoxicity of 4′-(9-acridinylamino)methanesulfon-m-anisidide without affecting DNA breakage and DNA topoisomerase II in a murine mastocytoma cell line. Biochemical Pharmacology 1989; 38: 263–269
   PubMed Web of Science ®Google Scholar
• Singh S.P., Lavin M.F. Study of DNA topoisomerase II in ataxiatelangiectasia cells. Carcinogenesis 1989; 10: 1215–1218
   PubMed Web of Science ®Google Scholar
• Singh S.P., Mohamed R., Salmond C., Lavin M.F. Reduced DNA topoisomerase II activity in ataxia-telangiectasia cells. Nucleic Acids Research 1988; 16: 3919–3929
   PubMed Web of Science ®Google Scholar
• Smith P.J., Anderson C.O. Modification of the radiation sensitivity of human tumour cells by a bis-benzimidazole derivative. International Journal of Radiation Biology 1984; 46: 331–344
   Web of Science ®Google Scholar
• Smith P.J., Makinson T.A. Cellular consequences overproduction of DNA topoisomerase II in an ataxia-telangiectasia cell line. Cancer Research 1989; 49: 1118–1124
   PubMed Web of Science ®Google Scholar
• Smith P.J., Bell S.M., Dee A., Sykes S. Involvement of DNA topoisomerase II in the selective resistance of a mamalian cell mutant to DNA minor groove ligands: ligand-induced DNA-protein crosslinking and responses to topoisomerase poisons. Carcinogenesis 1990; 11: 659–665
   PubMed Web of Science ®Google Scholar
• Smith P.J., Makinson T.A., Watson J.V. Enhanced sensitivity to camptothecin in ataxia-telangiectasia cells and its relationship with expression of DNA topoisomerase I. International Journal of Radiation Biology 1989; 55: 217–231
   PubMed Web of Science ®Google Scholar
• Takahashi K., Kaneko I. Changes in nuclease sensitivity of mammalian cells after irradiation with 60Co gamma-rays. International Journal of Radiation Biology 1985; 48: 389–395
   Web of Science ®Google Scholar
• Takahashi K., Kaneko I., Nishiyama C. Increase in the frequency of gammaray induced chromosomal aberrations in mammalian cells by post-treatment with novobiocin. International Journal of Radiation Biology 1986; 49: 657–663
   Web of Science ®Google Scholar
• Ullah S., Hussain I., Carlton W., Sancar A. Human nucleotide excision repair in vitro: repair of pyrimidine dimers, psoralen and cisplatin adducts by HeLa cell-free extract. Nucleic Acids Research 1989; 17: 4471–4484
   PubMed Web of Science ®Google Scholar
• Wallis J.W., Chrebet G., Brodsky G., Rolfe M., Rothstein R. A hyperrecombination mutation in S. cerevisiae identifies a novel eukaryotic topoisomerase. Cell 1989; 58: 409–419
   PubMed Web of Science ®Google Scholar
• Wang J.C. DNA topoisomerases. Annual Review of Biochemistry 1985; 54: 665–697
   PubMed Web of Science ®Google Scholar
• Warters R.L., Lyons B.W., Kennedy K., Li T.M. Topoisomerase activity in irradiated mammalian cells. Mutation Research 1989; 216: 43–55
   PubMedGoogle Scholar
• Woynarowski J.M., Sigmund R.D., Beerman T.A. Topoisomerase-II-mediated lesions in nascent DNA: comparison of the effects of epipodophyllotoxin derivatives, VM-26 and VP-16, and 9-anilinoacridine derivatives, m-AMSA and o-AMSA. Biochimica et Biophysica Acta 1988; 950: 21–29
   PubMedGoogle Scholar
• Woynarowski J.M., Sigmund R.D., Beerman T.A. DNA minor groove binding agents interfere with topoisomerase II mediated lesions induced by epipodophyllotoxin derivative VM-26 and acridine derivative m-AMSA in nuclei from L1210 cells. Biochemistry 1989; 28: 3850–3855
   PubMed Web of Science ®Google Scholar
• Zhang H., Wang J.C., Liu L.F. Involvement of DNA topoisomerase I in transcription of human ribosomal RNA genes. Proceedings of the National Academy of Sciences, USA 1988; 85: 1060–1064
   PubMed Web of Science ®Google Scholar